Healthcare Services

Losartan Market Developments and Growth Opportunities Across 2026–2030

April 2, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Losartan Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The losartan market size has shown consistent growth in recent years. Its value is anticipated to rise from $1.49 billion in 2025 to $1.55 billion in 2026, reflecting a compound annual growth rate (CAGR) of 4.2%. This past growth can be attributed to several factors including an increasing global prevalence of hypertension, the widespread clinical adoption of ARBs, a rising incidence of kidney disease linked to diabetes, improved public awareness concerning cardiovascular risk management, and an early transition from ACE inhibitors to ARBs.

The losartan market size is anticipated to demonstrate sustained expansion in the upcoming years, projected to reach $1.83 billion by 2030, reflecting a compound annual growth rate (CAGR) of 4.3%. This expected growth during the forecast period is largely influenced by an aging global demographic, a surging demand for medications that protect kidneys and reduce blood pressure, enhanced access to affordable generic versions, an increased focus on preventing strokes, and elevated healthcare spending directed towards the treatment of chronic conditions. Key trends identified for the forecast period encompass a rising prevalence of hypertension and various cardiovascular ailments, an escalating preference for ARBs over ACE inhibitors, a wider distribution of generic losartan prescriptions, its growing application in the management of diabetic nephropathy, and an increased embrace of long-term therapies for blood pressure control.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Losartan Market?

The increasing incidence of hypertension is projected to boost the expansion of the losartan market in the coming years. Hypertension is defined as a state characterized by sustained elevated blood pressure, which significantly elevates the risk of cardiac ailments, strokes, and various other serious health issues. The rising occurrence of hypertension is often associated with diets high in salt and processed foods, leading to fluid accumulation and increased strain on the heart. Losartan functions to manage hypertension by obstructing angiotensin II, a hormone responsible for constricting blood vessels. This action facilitates the relaxation and widening of these vessels, thereby reducing blood pressure and lessening the heart’s burden. As an illustration, in January 2025, the Centers for Disease Control and Prevention, a US-based organisation, reported that in 2023, high blood pressure was a primary or contributing factor in 664,470 deaths within the United States. Consequently, the escalating prevalence of hypertension is fueling the growth of the losartan market.

What Major Segment Divisions Exist Within The Losartan Market?

The losartan market covered in this report is segmented –

1) By Dosage: Tablet, Powder, Suspension

2) By Source: Contract Manufacturing Organizations, In-House

3) By Distribution Channel: Online, Offline

4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications

5) By End-User: Adult, Pediatric

Subsegments:

1) By Tablet: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

2) By Powder: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL), 10 Milligrams (mg) Per 5 Milliliters (mL), 25 Milligrams (mg) Per 5 Milliliters (mL)

What Trends Are Projected To Affect The Losartan Market?

Leading companies in the losartan market are concentrating on developing innovative products and securing approvals, such as losartan potassium oral suspension, to improve patient adherence and expand its therapeutic applications. Losartan potassium oral suspension is a liquid version of the losartan potassium medication, specifically formulated for individuals who find swallowing tablets challenging. For example, in March 2025, Scienture Holdings Inc., a biopharmaceutical company based in the US, was granted Food and Drug Administration (FDA) approval for Arbli. This product is a ready-to-use liquid formulation designed for hypertension, for reducing stroke risk in hypertensive patients with left ventricular hypertrophy, and for diabetic nephropathy in type 2 diabetes patients. It allows for precise dosing without compounding and is provided as a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life when stored at room temperature.

Which Companies Are Leading Innovation In The Losartan Market?

Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Read the full losartan market report here:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

What Are The Leading Geographic Regions In The Losartan Market?

North America was the largest region in the losartan market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Losartan Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24284&type=smp

Browse Through More Reports Similar to the Global Losartan Market 2026, By The Business Research Company

Lysine Global Market Report

https://www.thebusinessresearchcompany.com/report/lysine-global-market-report

Caviar Global Market Report

https://www.thebusinessresearchcompany.com/report/caviar-global-market-report

Liraglutide Global Market Report

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795